2019
High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best?
Kitchlu A, Shirali A. High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best? Journal Of Onco-Nephrology 2019, 3: 11-18. DOI: 10.1177/2399369319827305.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2015
Nephrotoxicity of Chemotherapy Agents
Valika A, Shirali A. Nephrotoxicity of Chemotherapy Agents. 2015, 65-91. DOI: 10.1007/978-1-4939-2659-6_4.Peer-Reviewed Original ResearchChemotherapy agentsAnti-vascular endothelial growth factor agentsEndothelial growth factor agentsChemotherapy-induced nephrotoxicityIntrinsic renal injurySite-specific injuryAcute tubular necrosisGrowth factor agentsGlomerular endothelial damageAdverse drug effectsDistinct clinical syndromeFactor agentsCrystal nephropathyHemodynamic statusPatient characteristicsRenal injuryTubular necrosisEndothelial damageKidney functionClinical syndromeVascular injuryKidney microenvironmentMalignant diseaseGlomerular diseaseDrug effects
2011
287 Nanoparticle Encapsulated Mycophenolic Acid Delays Murine Skin Allograft Rejection without Toxic Drug Effects
Shirali A, Look M, Fahmy T, Goldstein D. 287 Nanoparticle Encapsulated Mycophenolic Acid Delays Murine Skin Allograft Rejection without Toxic Drug Effects. American Journal Of Kidney Diseases 2011, 57: b88. DOI: 10.1053/j.ajkd.2011.02.290.Peer-Reviewed Original Research